China's Sinovac vaccine shows 50.38 pc efficacy in Brazil, less than claimed earlier

China's Sinovac vaccine shows 50.38 pc efficacy in Brazil, less than claimed earlier

Lokmat

The Chinese Sinovac vaccine has been found to be far less effective than vaccines developed by Pfizer-BioNTech and Moderna, according to a Brazil government statement on Tuesday, which raised questions about the lack of transparency of Chinese-made vaccines.

The Chinese Sinovac vaccine has been found to be far less effective than vaccines developed by Pfizer-BioNTech and Moderna, according to a Brazil government statement on Tuesday, which raised questions about the lack of transparency of Chinese-made vaccines.

The efficacy of the Chinese-made vaccine was 50.38 per cent in Brazil's late-stage trials.

While the number exceeds the threshold required for regulatory approval, it falls far below the 78 per cent previously announced, raising questions as to the veracity of the data and fueling skepticism over the apparent lack of transparency regarding Chinese vaccines, CNN reported.

Disclaimer: This is an automatically aggregated article/story by a computer program and has not been created or edited by Newsdig.in.

World COVID19 Meter

95009244

Cases

67554665

Recovered

2029869

Deaths
Last updated: GMT
Advt
Advt
Advt
sitemap Disclaimer
Newsdig.in 2019